Evidence map›Paper›PMID 40773457›Full record

ArticlePloS one2025

Health-related quality of life and QALY loss under COVID-19 lockdown: The case of Spain.

Mathieu F Janssen, Kim Rand, Anabel Estévez-Carrillo, Juan Manuel Ramos-Goñi

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mathieu F JanssenMaths In Health, Klimmen, The Netherlands.ORCID https://orcid.org/0000-0001-6602-6949
Kim RandMaths In Health, Klimmen, The Netherlands.
Anabel Estévez-CarrilloMaths In Health, Klimmen, The Netherlands.
Juan Manuel Ramos-GoñiMaths In Health, Klimmen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe COVID-19 pandemic forced many countries to implement confinement measures to limit the spread of the virus. Measuring the loss in terms of quality-adjusted life-years (QALYs) may provide a commensurable basis for comparing the impact of COVID-19. The aim of this research was to explore the impact of the first 21 days of COVID-19 lockdown on health-related quality of life (HRQoL) and associated QALY loss of the Spanish general population.

methodsA quota-based online survey was conducted in four waves with 500 general population respondents each: one conducted shortly before the lockdown (baseline) and 3 follow-ups conducted weekly. HRQoL data were collected using EQ-5D-5L. For comparison with pre-covid responses, data from the 2011-2012 National Health Survey was taken as reference. Data were analyzed using frequency analysis and logistic regression. QALY loss was estimated over the follow-up period and for the entire duration of the lockdown.

resultsComparing the baseline results to the follow-up results shows little change with respect to the distributions of reported problems in any of the 5 dimensions during the follow-up period. However, results for anxiety/depression show a 32% increase in the proportion of reported problems. The Spanish population was estimated to accrue a total of 1,994,216 QALYs over the study period. Based on the reference data, the population should have accrued 2,054,737 QALYs, leading to a loss of 60,520 QALYs over 21 days. For the entire lockdown, the corresponding loss would be 285,310 QALYs.

conclusionsA population under a lockdown situation reported higher rates of anxiety/depression problems than in a regular situation. On a country-wide scope, this may lead to a substantial loss in terms of QALYs, especially over longer periods of time. This is the first study to directly assess the impact of the lockdown in terms of QALY loss on a country-wide level.

Indexed as

COVID-19Quality-Adjusted Life YearsQuality of LifeQuarantineAdolescentAdultAgedAnxietyDepressionFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Spain

Identifiers

PMID40773457
PMCPMC12331123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.